People who have had a heart attack may be able to safely discontinue beta-blocker use after a year if they are at low-risk ...

A global clinical trial involving The Hospital for Sick Children (SickKids) has found that mavacamten—a heart medication ...

Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular ...

For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help protect your heart. But doctors are taking a closer look at whether ...

Heart disease continues to rank as the leading cause of death in the Black community, claiming thousands of lives annually. While lifestyle modifications remain foundational to heart health, modern ...

Researchers at the University of Bristol have identified a specific biological mechanism by which GLP-1 drugs, the same class of medications behind Ozempic and similar weight-loss treatments, may ...

When someone survives a heart attack, their recovery journey often includes a small pharmacy of medications—each serving a specific purpose in their healing process and long-term protection.

In their analysis, the authors evaluated the effects of commonly used cardiovascular medications in patients with multiple myeloma. These widely prescribed drugs, used to manage high blood pressure, ...

An increasing proportion of patients with heart failure receive a combination of four medications shown to improve prognosis ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...